Data from the London Marathon, with 650,000 completed runs, show that cardiac arrests occur even in the most experienced runners. Although coronary artery disease was the commonest cause of sudden cardiac arrest (SCA) with five deaths and six resuscitations, hypertrophic cardiomyopathy or idiopathic left ventricular hypertrophy (HCM) was diagnosed at autopsy on three occasions. HCM deaths had the same average age as the runners with ischaemic heart disease who had SCA or sudden cardiac death. The cardiac arrests were at the finish in less than one-third of cases and the remainder occurred between 6 and 26 miles on the course. Only one of the eight runners who died had reported symptoms to his family or physician suggestive of cardiac disease. The runner who had reported pre-race angina pain was investigated with a negative exercise stress test prior to the marathon and despite this died with a left anterior descending coronary artery stenosis. The cardiac death rate for the London Marathon is 1 in 80,000 finishers.

Download full-text PDF

Source
http://dx.doi.org/10.2165/00007256-200737040-00046DOI Listing

Publication Analysis

Top Keywords

london marathon
8
cardiac arrests
8
coronary artery
8
sudden cardiac
8
cardiac death
8
cardiac
6
marathon
4
marathon cardiac
4
cardiac deaths
4
deaths london
4

Similar Publications

There is growing consensus in the Alzheimer's community that combination therapy will be needed to maximize therapeutic benefits through the course of the disease. However, combination therapy raises complex questions and decisions for study sponsors, from preclinical research through clinical trial design to regulatory, statistical, and operational considerations. In January 2024, the Alzheimer's Drug Discovery Foundation convened an expert advisory board to discuss the key considerations in each of these areas.

View Article and Find Full Text PDF

The use of pain killers (NSAIDs) in athletes: How large is the risk?

J Sci Med Sport

November 2024

Brighton Marathon Research Group, United Kingdom of Great Britain and Northern Ireland; Department of Intensive Care, University Hospitals Sussex, United Kingdom of Great Britain and Northern Ireland; Brighton and Sussex Medical School, United Kingdom of Great Britain and Northern Ireland. Electronic address: https://twitter.com/drlhodgson.

Nonsteroidal anti-inflammatory drug use is prevalent in sport however the risk associated with their use in athletes is not well-understood. This review discusses the pharmacology of nonsteroidal anti-inflammatory drugs and the prevalence of their use in different sports and factors driving this. Use is very high in sports such as professional football and is sometimes by routine without indication and without medical supervision.

View Article and Find Full Text PDF

Background: The training characteristics and training intensity distribution (TID) of elite athletes have been extensively studied, but a comprehensive analysis of the TID across runners from different performance levels is lacking.

Methods: Training sessions from the 16 weeks preceding 151,813 marathons completed by 119,452 runners were analysed. The TID was quantified using a three-zone approach (Z1, Z2 and Z3), where critical speed defined the boundary between Z2 and Z3, and the transition between Z1 and Z2 was assumed to occur at 82.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores how circadian preference (morning vs. evening tendencies) and sleep inertia (feeling sluggish after waking) affect marathon performance, especially since marathons typically happen in the early morning.
  • Researchers recruited 936 participants from a 2016 city marathon and found that runners with a preference for the evening and higher sleep inertia tended to have slower completion times.
  • The findings suggest that understanding these factors could help tailor training programs for specific runners, potentially improving their performance during races.
View Article and Find Full Text PDF

The tauopathies are defined by pathological tau protein aggregates within a spectrum of clinically heterogeneous neurodegenerative diseases. The primary tauopathies meet the definition of rare diseases in the United States. There is no approved treatment for primary tauopathies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!